Quick Answer
Cardlytics, Inc. reported Total Assets of $285.64 million for the year ending 2025.
- Cardlytics, Inc. showed a decrease of -27.3% in Total Assets from 2024 to 2025.
- This data is from Cardlytics, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $157.81 million | Q2 2018: $140.25 million | Q3 2018: $138.07 million | Q1 2019: $146.47 million | Q2 2019: $143.56 million | Q3 2019: $193.25 million | Q1 2020: $206.08 million | Q2 2020: $183.04 million | Q3 2020: $389.42 million | Q1 2021: $1.02 billion | Q2 2021: $1.23 billion | Q3 2021: $1.22 billion | Q1 2022: $1.23 billion | Q2 2022: $1.09 billion | Q3 2022: $1.07 billion | Q1 2023: $684.60 million | Q2 2023: $633.32 million | Q3 2023: $634.92 million | Q1 2024: $568.95 million | Q2 2024: $534.37 million | Q3 2024: $399.39 million | Q1 2025: $369.07 million | Q2 2025: $361.13 million | Q3 2025: $292.81 million.
- Over the full 9 years of available data (2017 to 2025), Cardlytics, Inc.'s Total Assets has grown by 183.5%.
- Historical annual values: Fiscal year 2025: $285.64 million | Fiscal year 2024: $392.71 million | Fiscal year 2023: $574.14 million | Fiscal year 2022: $691.24 million | Fiscal year 2021: $1.26 billion | Fiscal year 2020: $422.54 million | Fiscal year 2019: $224.31 million | Fiscal year 2018: $153.76 million | Fiscal year 2017: $100.76 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: